
- Pharmaceutical Executive-03-01-2009
- Volume 0
- Issue 0
Flashpoint Medica for Indevus Pharmaceuticals's Supprelin LA
Flashpoint Medica's "Little girl, big shoes" campaign was used to portray the problem of central precocious puberty for the launch of Supprelin LA from Indevus Pharmaceuticals.
LITTLE GIRL, BIG SHOES
Flashpoint Medica
BRAND Supprelin LA CLIENT Indevus Pharmaceuticals FROM LEFT: Steve Frederick, evp, creative director; Shannon Fitzgerald, senior account executive; Helen Appelbaum, partner, chief operating officer; Kerry Baker, svp, associate creative director
Flashpoint Medica's "Little girl, big shoes" campaign was used to portray the problem of central precocious puberty for the launch of Supprelin LA from Indevus Pharmaceuticals. Little girls often play "dress up," but this condition makes them grow up too quickly. The marketing challenge was to convince physicians that a once-yearly implant to suppress hormones was preferred to painful monthly injections.
The series of feet-focused ads captures the essence of childhood freedom and playfulness, while conveying the message that Supprelin LA provides "a year of nonstop childhood." From a branding perspective, the strong use of the color pink conveyed that the condition primarily affects young girls.
"In pediatrician journals, you see a lot of faces. We wanted to stand out," says Steve Frederick, executive vice president, creative director. "Our whole imagery was centered on driving home the sense of freedom that a child feels when partaking in different activities."
The campaign has resonated with healthcare professionals and parents of children with this condition, as well as other key stakeholders and Indevus sales reps.
Articles in this issue
over 16 years ago
GSW Worldwide for MGI Pharma/Eisai's PONVover 16 years ago
Topin & Associates for Dusa's ClindaReachover 16 years ago
Saatchi & Saatchi for Sanofi-Aventis's Ambien CRover 16 years ago
Through the Looking Glassover 16 years ago
Wishbone for Barrier Thearpeutic's Vusionover 16 years ago
Fifth Annual Press Audit: Safety in the Spotlightover 16 years ago
Torre Lazur McCann for BMS & Sanofi Aventis's Plavixover 16 years ago
ICC for Sanofi Pasteur's TravelWise Programover 16 years ago
The New Sales Forceover 16 years ago
TBWA\WorldHealth for Schering-Plough's NuvaRingNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.





